Completed
Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)
NCT02667574
- Conditions
- Basal Cell Carcinoma, Carcinoma, Carcinoma, Basal Cell, +4 more
- Locations
-
- CHU de Besançon Besançon, France
- Hôpital St André Bordeaux, France
- CH de Boulogne sur mer Boulogne-sur-Mer, Boulogne Sur Mer, France
- CHU - Hôpital d'Estaing Clermont-Ferrand, France